Current Activities

Complete antibody development at UBC’s Biomedical Research Centre
Commence prototype development
Patent new discoveries
File ITA with Health Canada for internal standard developed for use in LC MS MS metabolite detection
Develop new compound and Mab for new additional substrate
Develop phase III trial design/markets and indications post pre-trial at SBRC in Manitoba Canada.
Submit revised protocol to Health Canada
Seek other detection technologies to reduce costs in the future
Seek phase III clinical trial centres in Canada and abroad
Kit placement in test markets
Accelerate point of care IVD kit post generation of monoclonal antibodies
Conduct double blinded studies for diagnostic systems are under development
Expand existing team at BioMark
Seek development and commercialization partners
Start and complete lung cancer response to treatment studies at CancerCare Manitoba


BioMark Technologies Summary

BioMark Summary (PDF)  [Right click to download]


Copyright 2014 by BioMark Tech. All Right Reserved.